Liver, Pancreas and Biliary TractPlacental growth factor levels neither reflect severity of portal hypertension nor portal-hypertensive gastropathy in patients with advanced chronic liver disease
Under a Creative Commons license
open access
Keywords
Cirrhosis
HVPG
PLGF
SFLT1
Angiogenesis
Portal-hypertensive gastropathy
Abbreviations
PLGF
placental growth factor
PH
portal hypertension
ACLD
advanced chronic liver disease
SFLT1/svegfr1
soluble FMS-like tyrosine kinase-1/soluble vascular endothelial growth factor receptor-1
HVPG
hepatic venous pressure gradient
PHG
portal-hypertensive gastropathy
c/dACLD
compensated/decompensated acld
AUROC
area-under-the-receiver operating characteristics
CSPH
clinically significant portal hypertension
VEGF
vascular endothelial growth factor
PPVL
partial portal vein ligation
CCl4
carbon tetrachloride
ALD
alcohol-related liver disease
HCC
hepatocellular carcinoma
TIPS
transjugular intrahepatic portosystemic shunt
NSBB
non-selective betablocker
SEM
standard error of the mean
IQR
interquartile range
CTP
Child-Turcotte-Pugh
MELD-Na
model for end-stage liver disease including sodium
HE
hepatic encephalopathy
PLT
platelets
HCV
hepatitis C
Cited by (0)
- 1
BeSi and AS contributed equally to this manuscript.
© 2020 The Authors. Published by Elsevier Ltd on behalf of Editrice Gastroenterologica Italiana S.r.l.